Chiral Tetradentate Research Articles

Oxidovanadium(V) Schiff Base Complexes Derived from Chiral 3-amino-1,2-propanediol Enantiomers: Synthesis, Spectroscopic Studies, Catalytic and Biological Activity.

Oxidovanadium(V) complexes, [(+)VOL1-5] and [(-)VOL1-5], with chiral tetradentate Schiff bases, which are products of monocondensation of S(‒)-3-amino-1,2-propanediol or R(+)-3-amino-1,2-propanediol with salicylaldehyde derivatives, have been synthesized. Different spectroscopic methods, viz. 1H and 51V NMR, IR, UV-Vis, and circular dichroism, as well as elemental analysis, have been used for their detailed characterization. Furthermore, the epoxidation of styrene, cyclohexene, and two monoterpenes, S(‒)-limonene and (‒)-α-pinene, using two oxidants, aqueous 30% H2O2 or tert-butyl hydroperoxide (TBHP) in decane, has been studied with catalytic amounts of all complexes. Finally, biological cytotoxicity studies have also been performed with these oxidovanadium(V) compounds for comparison with cis-dioxidomolybdenum(VI) Schiff base complexes with the same chiral ligands, as well as to determine the cytoprotection against the oxidative damage caused by 30% H2O2 in the HT-22 hippocampal neuronal cells in the range of their 10-100 μM concentration.

Oxidovanadium(V) complexes with chiral tetradentate Schiff bases: Synthesis, spectroscopic characterization, catalytic and biological activity

New mononuclear oxidovanadium(V) complexes, [(−)VOL1–10] and [(+)VOL1–4], with chiral tetradentate Schiff bases have been obtained by monocondensation of salicylaldehyde derivatives and optically active amino alcohols, i.e. 1R,2R-(−)-2-amino-1-phenyl-1,3-propanediol or 1S,2S-(+)-2-amino-1-phenyl-1,3-propanediol. All complexes have been characterized by elemental analysis, circular dichroism, UV–vis, IR, 1D (1H, 51V) and 2D (COSY, NOESY) NMR spectroscopy. The catalytic activity studies have also been performed for all complexes in the epoxidation of styrene, cyclohexene and two monoterpenes, i.e. S(−)-limonene and (−)-α-pinene, using aqueous 30 % H2O2 or tert-butyl hydroperoxide (TBHP) as the terminal oxidant. In addition, biological properties of these chiral oxidovanadium(V) compounds, as well as cis-dioxidomolybdenum(VI) complexes with the same chiral Schiff bases, were studied in relation to their cytoprotective activity against the oxidative damage generated exogenously by 30 % hydrogen peroxide in the HT-22 hippocampal neuronal cells. The latter compounds have revealed distinct cytoprotective properties causing the highest increase in the viability of HT-22 cells. Concentration dependent effect in the range of 10-100 μM concentration of the investigated compounds has also been observed.

Synthesis, Spectroscopic Characterization, Catalytic and Biological Activity of Oxidovanadium(V) Complexes with Chiral Tetradentate Schiff Bases

New oxidovanadium(V) complexes, VOL1–VOL10, with chiral tetradentate Schiff bases obtained by monocondensation reaction of salicylaldehyde derivatives with 1S,2S-(+)-2-amino-1-(4-nitrophenyl)-1,3-propanediol. All complexes have been characterized using different spectroscopic methods, viz. IR, UV-Vis, circular dichroism, one- (1H, 51V) and two-dimensional (COSY, NOESY) NMR spectroscopy, and elemental analysis. Furthermore, the catalytic ability of all compounds in the epoxidation of styrene, cyclohexene, and its naturally occurring monoterpene derivatives, i.e., S(−)-limonene and (−)-α-pinene has also been studied, using two different oxidants, i.e., aqueous 30% H2O2 or tert-butyl hydroperoxide (TBHP). In addition, the biological properties of these chiral oxidovanadium(V) compounds, but also cis-dioxidomolybdenum(VI) complexes with the same chiral Schiff bases, were studied. Their cytotoxic and cytoprotective activity studies with the HT-22 hippocampal neuronal cells revealed a concentration-dependent effect in the range of 10–100 μM. Moreover, vanadium(V) complexes, in contrast to cis-dioxidomolybdenum(VI) compounds, demonstrated higher cytotoxicity and lack of cytoprotective ability against H2O2-induced cytotoxicity.

Asymmetric Hydrogenation of Tetrapyridine‐Type N‐Heteroarenes Using Phosphine‐Free Ruthenium Diamine Catalysts†

Comprehensive SummaryChiral ruthenium‐catalyzed enantioselective hydrogenation of tetrapyridine‐type N‐heteroarenes was firstly developed. The partial reduction of adjacent tetraheteroaromatic substrates proceeded smoothly in the presence of phosphine‐free chiral cationic ruthenium diamine complexes, affording unprecedented high reactivity, enantioselecitivity and diastereoselectivity (up to 93% yield, >99% ee and 92 : 8 dr). The potential application of chiral tetradentate pyridine‐amine products as chiral ligands has been demonstrated in the Cu‐catalyzed asymmetric Friedel–Crafts alkylation reaction between indoles and nitroalkenes.

Trading Symmetry for Stereoinduction in Tetradentate, non-C2 -Symmetric Fe(II)-Complexes for Asymmetric Catalysis.

A series of stereogenic-at-metal iron complexes comprising a non-C2 -symmetric chiral topology is introduced and applied to asymmetric 3d-transition metal catalysis. The chiral iron(II) complexes are built from chiral tetradentate N4-ligands containing a proline-derived amino pyrrolidinyl backbone which controls the relative (cis-α coordination) and absolute metal-centered configuration (Λ vs. Δ). Two chloride ligands complement the octahedral coordination sphere. The modular composition of the tetradentate ligands facilitates the straightforward incorporation of different terminal coordinating heteroaromatic groups into the scaffold. The influence of various combinations was evaluated in an asymmetric ring contraction of isoxazoles to 2H-azirines revealing that a decrease of symmetry is beneficial for the stereoinduction to obtain chiral products in up to 99 % yield and with up to 92 % ee. Conveniently, iron catalysis is feasible under open flask conditions with the bench-stable dichloro complexes exhibiting high robustness towards oxidative or hydrolytic decomposition. The versatility of non-racemic 2H-azirines was subsequently showcased with the conversion into a variety of quaternary α-amino acid derivatives.

Molybdenum(VI) complexes with a chiral l-alanine bisphenol [O,N,O,O’] ligand. Synthesis, structure, spectroscopic properties and catalytic activity

Dioxidomolybdenum(VI) compound [MoO2Cl2(dmso)2] reacts with a chiral tetradentate O3N-type l-alanine bisphenol ligand precursor (Et3NH)H2Lala to form an oxidochloridomolybdenum(VI) complex [MoOCl(Lala)] (1) as two separable geometric isomers with phenolate groups in cis or trans positions. The single crystal X-ray and NMR analyses of cis- and trans-1 reveal that the complexes are formed of monomeric molecules, in which the ligand has a tetradentate coordination through three oxygen donors and one nitrogen donor. The reaction of Na2MoO4·2H2O with the same ligand precursor in an acidic methanol solution leads to the formation of an anionic dioxido complex (Et3NH)[MoO2(Lala)] (2) with a trans coordination of the tetradentate ligand. Trans-1 and 2 were studied as active catalysts for olefin epoxidation: i.e. styrene, cyclohexene, S(–)-limonene and (–)-α-pinene using H2O2 and tBuOOH as oxidants.

Enantioselectivity-Evaluation of Chiral Copper(II) Complexes Coordinated by Novel Chiral Tetradentate Ligands for Free Amino Acids by Mass Spectrometry Coupled With the Isotopically Labeled Enantiomer Method.

A series of copper(II) complexes with chiral tetradentate ligands, N,N′-ethylene- bis(S-amino acid methyl amide or methyl ester) prepared from S-alanine, S-phenylalanine, S-valine or S-proline, was generated in methanol. The copper complexes provided three component complexes in the presence of a free chiral amino acid. The enantioselectivity for the amino acid was evaluated by electrospray ionization-mass spectrometry coupled with the deuterium-labeled enantiomer method and these copper complexes were found to exhibit high enantioselectivity for free amino acids having bulky side chains. This result suggests that steric interaction between the tetradentate ligand and free amino acid was a major factor in chiral recognition. The copper complex with a chiral tetradentate ligand prepared from S-proline showed opposite enantioselectivity to copper complexes consisting of tetradentate ligands prepared from other S-amino acids. The conformational difference of the tetradentate ligand in the copper complex was found to be significant for enantioselectivity.

Effect of Ligand Topology on the Reactivity of Chiral Tetradentate Aminopyridine Manganese Complexes

In recent years, bioinspired manganese and iron complexes bearing linear tetradentate aminopyridine (N4) ligands have emerged as highly efficient catalysts in asymmetric oxidation reactions using h...

Synthesis, spectroscopic characterization and catalytic activity of cis‐dioxidomolybdenum (VI) complexes with chiral tetradentate Schiff bases

New chiral mononuclear cis‐dioxidomolybdenum (VI) complexes, MoO2L1–MoO2L10, with tetradentate Schiff bases derived from various substituted salicylaldehydes and 1S,2S‐(+)‐2‐amino‐1‐(4‐nitrophenyl)‐1,3‐propanediol were synthesized. All complexes were characterized by elemental analysis, circular dichroism, electronic and IR spectroscopy. 1H NMR and also two‐dimensional (COSY, NOESY and gHSQC) NMR measurements made for MoO2L1–MoO2L10 complexes show that Schiff bases are coordinated to the MoO22+ cation, creating facial (fac) and meridional (mer) types of geometrical isomers. Moreover, catalytic activity studies were also performed for all complexes in asymmetric sulfoxidation of thioanisole and epoxidation of styrene, cyclohexene and two monoterpenes, i.e. S(−)‐limonene and (−)‐α‐pinene, using aqueous 30% H2O2 or tert‐butyl hydroperoxide as the oxygen source.

Cis-dioxidomolybdenum(VI) complexes with chiral tetradentate Schiff bases: Synthesis, spectroscopic characterization and catalytic activity in sulfoxidation and epoxidation

New chiral mononuclear cis-dioxidomolybdenum(VI) complexes, MoO2L1-MoO2L7, have been synthesized by the reaction of MoO2(acac)2 with tetradentate Schiff bases derived from various substituted salicylaldehydes and 1S,2S-(+)-2-amino-1-phenyl-1,3-propanediol. All complexes have been characterized by elemental analysis, circular dichroism, electronic and IR spectral studies. 1H NMR and also two-dimensional (COSY, NOESY and gHSQC) NMR measurements made for MoO2L1-MoO2L7 complexes show that Schiff bases are coordinated to MoO22+ cation creating facial (fac) and meridional (mer) types of geometrical isomers. Moreover, the catalytic activity studies have been also performed for all complexes in asymmetric sulfoxidation of thioanisole and epoxidation of styrene, cyclohexene and two monoterpenes, i.e. S(−)-limonene and (−)-α-pinene, using aqueous 30% H2O2 or tert-butyl hydroperoxide (TBHP) as the oxygen source.

Synthesis, Characterization, and In Vitro Cytotoxicity of Platinum(II) Complexes Bearing Chiral Tetradentate Salicylaldimine Ligands

A series of platinum(II) complexes with chiral Schiff base ligands derived from various salicylaldehydes with (R,R′)- and (S,S′)-cyclohexanediamine were synthesized and characterized by ESI-MS, IR, and NMR. Obtained spectra with typical signals were in agreement with suggested molecular formulae of the complexes. Their photophysical properties were studied by UV-visible and emission spectroscopies. The UV-Vis showed the typical band with low energy at visible range 400–500 nm for MLCT, and this band can emit the luminescent band with emission maximum wavelengths at 529–595 nm. The in vitro cytotoxicity of obtained platinum(II) complexes was screened for KB and MCF-7 human cancer cell lines. The results showed that (S)-enantiomers were more active than (R)-enantiomers and the different positions of methoxy group in salicyl ring gave different cytotoxicities.

Mass spectrometric detection of enantioselectivity in three-component complexation, copper(ii)-chiral tetradentate ligand-free amino acid in solution.

By using electrospray ionization mass spectrometry coupled with the use of deuterium-labelled quasienantiomers, enantioselective coordination of a free amino acid as the second ligand of a copper(ii) complex with a novel chiral tetradentate ligand was evaluated quantitatively in a short measurement time.

Highly enantioselective epoxidation of olefins by H2O2 catalyzed by a non-heme Fe(ii) catalyst of a chiral tetradentate ligand.

The chiral tetradentate N4-donor ligand, 1-methyl-2-({(S)-2-[(S)-1-(1-methylbenzimidazol-2-yl methyl)pyrrolidin-2-yl]pyrrolidin-1-yl}methyl) benzimidazole (S,S-PDBzL), based on a chiral dipyrrolidine backbone, has been synthesized and its corresponding Fe(ii) complex has been prepared and characterized. The X-ray structure of the complex reveals that the Fe(ii) ion is in a distorted octahedral coordination environment with two cis-oriented coordination sites occupied by (labile) triflate anions. The ability of the iron complex to catalyze asymmetric epoxidation reactions of olefins with H2O2 was investigated, using 2-cyclohexen-1-one, 2-cyclopenten-1-one, cis-β-methylstyrene, isophorone, chalcones and tetralones as substrates. Different carboxylic acids were used as additives to enhance yields and enantioselectivities, and 2-ethylhexanoic acid was found to give the best results. The catalysis results indicate that the Fe(ii) complex is capable of effecting comparatively high enantioselectivities (>80%) in the epoxidation reactions.

Cis-Oxoruthenium complexes supported by chiral tetradentate amine (N4) ligands for hydrocarbon oxidations.

We report the first examples of ruthenium complexes cis-[(N4)RuIIICl2]+ and cis-[(N4)RuII(OH2)2]2+ supported by chiral tetradentate amine ligands (N4), together with a high-valent cis-dioxo complex cis-[(N4)RuVI(O)2]2+ supported by the chiral N4 ligand mcp (mcp = N,N'-dimethyl-N,N'-bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine). The X-ray crystal structures of cis-[(mcp)RuIIICl2](ClO4) (1a), cis-[(Me2mcp)RuIIICl2]ClO4 (2a) and cis-[(pdp)RuIIICl2](ClO4) (3a) (Me2mcp = N,N'-dimethyl-N,N'-bis((6-methylpyridin-2-yl)methyl)cyclohexane-1,2-diamine, pdp = 1,1'-bis(pyridin-2-ylmethyl)-2,2'-bipyrrolidine)) show that the ligands coordinate to the ruthenium centre in a cis-α configuration. In aqueous solutions, proton-coupled electron-transfer redox couples were observed for cis-[(mcp)RuIII(O2CCF3)2]ClO4 (1b) and cis-[(pdp)RuIII(O3SCF3)2]CF3SO3 (3c'). Electrochemical analyses showed that the chemically/electrochemically generated cis-[(mcp)RuVI(O)2]2+ and cis-[(pdp)RuVI(O)2]2+ complexes are strong oxidants with E° = 1.11-1.13 V vs. SCE (at pH 1) and strong H-atom abstractors with DO-H = 90.1-90.8 kcal mol-1. The reaction of 1b or its (R,R)-mcp counterpart with excess (NH4)2[CeIV(NO3)6] (CAN) in aqueous medium afforded cis-[(mcp)RuVI(O)2](ClO4)2 (1e) or cis-[((R,R)-mcp)RuVI(O)2](ClO4)2 (1e*), respectively, a strong oxidant with E(RuVI/V) = 0.78 V (vs. Ag/AgNO3) in acetonitrile solution. Complex 1e oxidized various hydrocarbons, including cyclohexane, in acetonitrile at room temperature, affording alcohols and/or ketones in up to 66% yield. Stoichiometric oxidations of alkenes by 1e or 1e* in t BuOH/H2O (5 : 1 v/v) afforded diols and aldehydes in combined yields of up to 98%, with moderate enantioselectivity obtained for the reaction using 1e*. The cis-[(pdp)RuII(OH2)2]2+ (3c)-catalysed oxidation of saturated C-H bonds, including those of ethane and propane, with CAN as terminal oxidant was also demonstrated.

Structures of cis-dioxomolybdenum(VI) with chiral tetradentate tripodal ligands

Structures of <i>cis</i>-dioxomolybdenum(VI) with chiral tetradentate tripodal ligands

Synthesis and in vitro cytotoxicity of novel dinuclear platinum(II) complexes containing a chiral tetradentate ligand

A series of novel dinuclear platinum(II) complexes with a chiral tetradentate ligand, (1R,1′R,2R,2′R)-N1,N1′-(1,2-phenylenebis(methylene))dicyclohexane-1,2-diamine (HL), and mono-carboxylic acid derivatives as ligands have been designed, synthesized, and characterized. In vitro cytotoxicity evaluation of synthesized complexes against human HepG-2, A549, HCT-116, and MCF-7 cancer cell lines has been conducted by MTT assays. All compounds showed antitumor activity to HepG-2 and HCT-116 cell lines. Compound L2 exhibited better cytotoxicity than that of carboplatin against HepG-2 and A549 cell lines and also showed comparable activity against HCT-116 cell line.

Evidence of a Sole Oxygen Atom Transfer Agent in Asymmetric Epoxidations with Fe-pdp Catalysts

Iron complexes with chiral tetradentate ligands based on the pdp scaffold (pdp = N,N′-bis(2-pyridylmethyl)-2,2′-bipyrrolidine) are efficient and versatile catalysts for the highly enantioselective epoxidation of a wide range of olefins. The nature of the species responsible for oxygen atom transfer to the olefin in these reactions is under debate. In order to investigate this question, the enantioselectivity of the epoxidation reaction has been used as a mechanistic probe. The enantioselectivities obtained under different reaction conditions for two iron catalysts (S,S)-[Fe(CF3SO3)2(Me2Npdp)] ((S,S)Me2N1Fe) and (S,S)-[Fe(CF3SO3)2(dMMpdp)] ((S,S)dMM1Fe) have been analyzed. Reactions were performed with a series of peracids, and enantioselectivities of these reactions were compared with those obtained by combining peroxides and carboxylic acids. This analysis provides conclusive experimental evidence that the same oxidant is responsible for the asymmetric epoxidation reaction in both scenarios. The study al...

Design, synthesis and biological evaluation of six dinuclear platinum(II) complexes

Six dinuclear platinum(II) complexes with a chiral tetradentate ligand, (1R,1′R,2R,2′R)-N1,N1′-(1,4-phenylenebis(methylene))dicyclohexane-1,2-diamine, have been designed, synthesized and characterized. In vitro cytotoxicity evaluation of these metal complexes against human A549, HCT-116, MCF-7 and HepG-2 cell lines have been carried out. All compounds showed antitumor activity to HepG-2, HCT-116 and A549. Particularly, compounds A1 and A2 exhibited significant better activity than other four compounds and A2 even showed comparable cytotoxicity to cisplatin against HepG-2 cell line.

Complexes of cis-dioxomolybdenum(VI) with a chiral tetradentate tripodal-like ligand system: Syntheses, structures and catalytic activities

Racemic complexes with the general formula cis-[MoO2(bzacLn)] (1–4) (H2bzacLn=2-((4/5-R-2-hydroxyphenylamino)(pyridin-2-yl)methyl)-1-phenylbutane-1,3-dione, where n=1–4 for R=H, 5-Me, 5-Cl and 4-Me, respectively and 2Hs represent the dissociable phenolic proton and the active tertiary CH proton) have been synthesized in 75–82% yields by reacting [MoO2(bzac)2] (Hbzac=benzoylacetone) with the potentially N2O-donor 5,5-membered fused chelate rings forming Schiff bases 4/5-R-2-(2-pyridylaldimine)phenols (HLn; n=1–4 for R=H, 4-Me, 4-Cl and 5-Me, respectively) in hot methanol. The chiral ligand system (bzacLn)2− in 1–4 is formed via metal assisted Mannich-type addition of benzoylacetonate methine to the azomethine fragment of HLn. All four complexes have been characterized by elemental (CHN) analysis, solution conductivity, magnetic susceptibility, spectroscopic (IR, UV–Vis and NMR) and electrochemical measurements. The molecular structures of 1–3 have been established by single crystal X-ray crystallography. In each complex, the chiral (bzacLn)2− acts as a tetradentate, N2O2-donor, tripodal-like ligand system and along with the two mutually cis oxo groups forms a distorted octahedral N2O4 coordination environment around the molybdenum(VI) center. All four complexes are diamagnetic and non-electrolytic. The infrared spectra are generally consistent with the structural formulas of 1–4. The electronic spectra of 1–4 in dimethylformamide display two strong absorption bands in the range 245–300nm. The cyclic voltammograms of 1–4 in dimethylformamide exhibit a metal centered one-electron reduction response within −0.64 to −0.74V. All these complexes (1–4) and the analogous cis-[MoO2(acacL1–4)] (5–8) synthesized from [MoO2(acac)2] (Hacac=acetylacetone) and HL1–4 have been evaluated for their bromoperoxidase activities.

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Seven dinuclear platinum(II) complexes with a novel chiral tetradentate ligand, (1R,1′R,2R,2′R)‐N1,N1′‐(1,4‐phenylenebis(methylene))dicyclohexane‐1,2‐diamine, were designed, synthesized and spectrally characterized. All the complexes were evaluated for their in vitro cytotoxicity against human HepG‐2, A549, HCT‐116 and MCF‐7 cancer cell lines. The results indicated that all compounds showed positive biological activity against HepG‐2, A549 and HCT‐116 cancer cell lines. In particular, compounds D7 and D2 showed better activity than carboplatin against HepG‐2 and A549 and compound D7 also showed an activity close to that of oxaliplatin. Copyright © 2015 John Wiley &amp; Sons, Ltd.